Radiopharmaceutiques et métastases osseuses : quelles molécules pour quels patients et dans quelles indications ?
Crossref DOI link: https://doi.org/10.1007/s10269-015-2498-z
Published Online: 2015-03-20
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dubreuil, J.
Houzard, C.
Saddoune, K.
Giammarile, F.
Text and Data Mining valid from 2015-03-01
